![]() | Up a level |
Journal Article
Smolen, Josef S., Landewe, Robert, Bijlsma, Johannes, Burmester, Gerd, Chatzidionysiou, Katerina, Dougados, Maxime, Nam, Jackie, Ramiro, Sofia, Voshaar, Marieke, van Vollenhoven, Ronald, Aletaha, Daniel, Aringer, Martin ORCID: 0000-0003-4471-8375, Boers, Maarten, Buckley, Chris D., Buttgereit, Frank, Bykerk, Vivian, Cardiel, Mario, Combe, Bernard, Cutolo, Maurizio, van Eijk-Hustings, Yvonne, Emery, Paul, Finckh, Axel, Gabay, Cem, Gomez-Reino, Juan, Gossec, Laure, Gottenberg, Jacques-Eric, Hazes, Johanna M. W., Huizinga, Tom, Jani, Meghna
ORCID: 0000-0002-1487-277X, Karateev, Dmitry, Kouloumas, Marios, Kvien, Tore, Li, Zhanguo, Mariette, Xavier, McInnes, Iain, Mysler, Eduardo, Nash, Peter
ORCID: 0000-0002-2571-788X, Pavelka, Karel
ORCID: 0000-0003-1952-8422, Poor, Gyula, Richez, Christophe, van Riel, Piet, Rubbert-Roth, Andrea, Saag, Kenneth, da Silva, Jose, Stamm, Tanja, Takeuchi, Tsutomu
ORCID: 0000-0003-1111-8218, Westhovens, Rene, de Wit, Maarten and van der Heijde, Desiree
ORCID: 0000-0002-5781-158X
(2017).
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
Ann. Rheum. Dis., 76 (6).
S. 960 - 978.
LONDON:
BMJ PUBLISHING GROUP.
ISSN 1468-2060
Smolen, Josef S., Landewe, Robert, Breedveld, Ferdinand C., Buch, Maya ORCID: 0000-0002-8962-5642, Burmester, Gerd, Dougados, Maxime, Emery, Paul, Gaujoux-Viala, Cecile
ORCID: 0000-0002-2099-6496, Gossec, Laure, Nam, Jackie, Ramiro, Sofia, Winthrop, Kevin, de Wit, Maarten, Aletaha, Daniel, Betteridge, Neil, Bijlsma, Johannes W. J., Boers, Maarten, Buttgereit, Frank
ORCID: 0000-0003-2534-550X, Combe, Bernard, Cutolo, Maurizio, Damjanov, Nemanja, Hazes, Johanna M. W., Kouloumas, Marios, Kvien, Tore K., Mariette, Xavier, Pavelka, Karel
ORCID: 0000-0003-1952-8422, van Riel, Piet L. C. M., Rubbert-Roth, Andrea, Scholte-Voshaar, Marieke, Scott, David L., Sokka-Isler, Tuulikki, Wong, John B. and van der Heijde, Desiree
ORCID: 0000-0002-5781-158X
(2014).
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.
Ann. Rheum. Dis., 73 (3).
S. 492 - 510.
LONDON:
BMJ PUBLISHING GROUP.
ISSN 1468-2060
Taylor, Peter C., Krogulec, Marek, Dudek, Anna, Dudler, Jean, Drescher, Edit, Cseuz, Regina, Kausiene, Rasa, Andersone, Daina, Unikiene, Dalia, Sanchez Burson, Juan, Blanco Alonso, Ricardo, Dvorak, Zdenek, Ghizdavescu, Andrei, Irto, Ildiko, Larsson, Esbjorn, Bello, Natalia, Barry, Jane, Durand, Frederick, Holzkaemper, Thorsten, Otawa, Susan, de Bono, Stephanie, Keystone, Edward C., Rubbert-Roth, Andrea, Combe, Bernard and De La Torre, Inmaculada (2017). EFFICACY AND SAFETY OF BARICITINIB VERSUS PLACEBO AND ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: SUMMARY RESULTS FROM THE 52-WEEK PHASE 3 RA-BEAM STUDY. RHEUMATOLOGY, 56. S. 26 - 28. OXFORD: OXFORD UNIV PRESS. ISSN 1462-0332